Cargando…

Autoantibodies from Patients with Scleroderma Renal Crisis Promote PAR-1 Receptor Activation and IL-6 Production in Endothelial Cells

Background. Scleroderma renal crisis (SRC) is a life-threatening complication of systemic sclerosis (SSc). Autoantibodies (Abs) against endothelial cell antigens have been implicated in SSc and SRC. However, their detailed roles remain poorly defined. Pro-inflammatory cytokine interleukin-6 (IL-6) h...

Descripción completa

Detalles Bibliográficos
Autores principales:	Simon, Michèle, Lücht, Christian, Hosp, Isa, Zhao, Hongfan, Wu, Dashan, Heidecke, Harald, Witowski, Janusz, Budde, Klemens, Riemekasten, Gabriela, Catar, Rusan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8584031/ https://www.ncbi.nlm.nih.gov/pubmed/34769227 http://dx.doi.org/10.3390/ijms222111793

Ejemplares similares

Autoantibodies from patients with kidney allograft vasculopathy stimulate a proinflammatory switch in endothelial cells and monocytes mediated via GPCR-directed PAR1-TNF-α signaling
por: Moll, Guido, et al.
Publicado: (2023)

Transcriptional Regulation of Thrombin-Induced Endothelial VEGF Induction and Proangiogenic Response
por: Catar, Rusan, et al.
Publicado: (2021)

Native and Oxidized Low-Density Lipoproteins Increase the Expression of the LDL Receptor and the LOX-1 Receptor, Respectively, in Arterial Endothelial Cells
por: Catar, Rusan, et al.
Publicado: (2022)

IL-17 in Peritoneal Dialysis-Associated Inflammation and Angiogenesis: Conclusions and Perspectives
por: Witowski, Janusz, et al.
Publicado: (2018)

Expanded Hemodialysis ameliorates uremia-induced impairment of vasculoprotective KLF2 and concomitant proinflammatory priming of endothelial cells through an ERK/AP1/cFOS-dependent mechanism
por: Zhao, Hongfan, et al.
Publicado: (2023)

Autoantibodies in Serum of Systemic Scleroderma Patients: Peptide-Based Epitope Mapping Indicates Increased Binding to Cytoplasmic Domains of CXCR3
por: Recke, Andreas, et al.
Publicado: (2018)

Autoantibodies Targeting AT(1)- and ET(A)-Receptors Link Endothelial Proliferation and Coagulation via Ets-1 Transcription Factor
por: Catar, Rusan, et al.
Publicado: (2021)

Nailfold Videocapillaroscopy for Non-Invasive Assessment of Microcirculation and Prognostic Correlation with Endothelial Dysfunction, Cardiovascular Risk Factors, and Non-HLA Antibodies in Heart Transplant Recipients: A Pilot Study
por: Sikorska, Dorota, et al.
Publicado: (2023)

Angiogenic Role of Mesothelium-Derived Chemokine CXCL1 During Unfavorable Peritoneal Tissue Remodeling in Patients Receiving Peritoneal Dialysis as Renal Replacement Therapy
por: Catar, Rusan Ali, et al.
Publicado: (2022)

The clinical relevance of autoantibodies in scleroderma
por: Ho, Khanh T, et al.
Publicado: (2003)

Regulation of Chemokine CCL5 Synthesis in Human Peritoneal Fibroblasts: A Key Role of IFN-γ
por: Kawka, Edyta, et al.
Publicado: (2014)

Transfer of PBMC From SSc Patients Induces Autoantibodies and Systemic Inflammation in Rag2-/-/IL2rg-/- Mice
por: Yue, Xiaoyang, et al.
Publicado: (2021)

Angiotensin receptor type 1 and endothelin receptor type A on immune cells mediate migration and the expression of IL-8 and CCL18 when stimulated by autoantibodies from systemic sclerosis patients
por: Günther, Jeannine, et al.
Publicado: (2014)

Specific Autoantibodies in Neovascular Age-Related Macular Degeneration: Evaluation of Morphological and Functional Progression over Five Years
por: Prasuhn, Michelle, et al.
Publicado: (2021)

What Makes Antibodies Against G Protein-Coupled Receptors so Special? A Novel Concept to Understand Chronic Diseases
por: Riemekasten, Gabriela, et al.
Publicado: (2020)

Molecular Effects of Auto-Antibodies on Angiotensin II Type 1 Receptor Signaling and Cell Proliferation
por: Philippe, Aurélie, et al.
Publicado: (2022)

Intrinsic Deregulation of Vascular Smooth Muscle and Myofibroblast Differentiation in Mesenchymal Stromal Cells from Patients with Systemic Sclerosis
por: Hegner, Björn, et al.
Publicado: (2016)

Clinical phenotype in scleroderma patients based on autoantibodies
por: Santos, Cristiana Sieiro, et al.
Publicado: (2023)

Antibodies against chemokine receptors CXCR3 and CXCR4 predict progressive deterioration of lung function in patients with systemic sclerosis
por: Weigold, Florian, et al.
Publicado: (2018)

Expanded Hemodialysis Therapy Ameliorates Uremia-Induced Systemic Microinflammation and Endothelial Dysfunction by Modulating VEGF, TNF-α and AP-1 Signaling
por: Catar, Rusan, et al.
Publicado: (2021)

Renal Crisis as the Initial Manifestation of Scleroderma
por: Gandhi, Ronak, et al.
Publicado: (2022)

ACE inhibitors in SSc patients display a risk factor for scleroderma renal crisis—a EUSTAR analysis
por: Bütikofer, Lukas, et al.
Publicado: (2020)

Autoantibodies to Vasoregulative G-Protein-Coupled Receptors Correlate with Symptom Severity, Autonomic Dysfunction and Disability in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
por: Freitag, Helma, et al.
Publicado: (2021)

Autoantibodies to angiotensin and endothelin receptors in systemic sclerosis induce cellular and systemic events associated with disease pathogenesis
por: Kill, Angela, et al.
Publicado: (2014)

Scleroderma Renal Crisis: A Pathology Perspective
por: Batal, Ibrahim, et al.
Publicado: (2010)

Scleroderma Renal Crisis in a Normotensive Patient
por: Asamoah-Odei, Efua
Publicado: (2016)

Patient with ankylosing spondylitis and scleroderma renal crisis
por: Venetsanopoulou, Aliki I., et al.
Publicado: (2018)

Tozinameran: Scleroderma renal crisis: case report
Publicado: (2022)

181 Scleroderma Renal Crisis and COVID—Is There an Association?
Publicado: (2022)

Frequency of disease-associated and other nuclear autoantibodies in patients of the German network for systemic scleroderma: correlation with characteristic clinical features
por: Mierau, Rudolf, et al.
Publicado: (2011)

Association of anti-RNA polymerase III autoantibodies and cancer in scleroderma
por: Moinzadeh, Pia, et al.
Publicado: (2014)

Investigation of myositis and scleroderma specific autoantibodies in patients with lung cancer
por: Betteridge, Zoe E., et al.
Publicado: (2018)

Combinations of scleroderma hallmark autoantibodies associate with distinct clinical phenotypes
por: Clark, Kristina E. N., et al.
Publicado: (2022)

Paclitaxel-induced diffuse scleroderma with possible scleroderma-renal crisis: a case report and literature review of taxanes-induced scleroderma
por: Ketpueak, Thanika, et al.
Publicado: (2022)

Autoantibodies as Biomarker and Therapeutic Target in Systemic Sclerosis
por: Graßhoff, Hanna, et al.
Publicado: (2022)

Severe COVID-19 patients exhibit elevated levels of autoantibodies targeting cardiolipin and platelet glycoprotein with age: a systems biology approach
por: Fonseca, Dennyson Leandro M., et al.
Publicado: (2023)

Complement activation and effect of eculizumab in scleroderma renal crisis
por: Devresse, Arnaud, et al.
Publicado: (2016)

Diffused Alveolar Hemorrhage in the Setting of Scleroderma Renal Crisis
por: Henao, Jose, et al.
Publicado: (2019)

Systemic sclerosis medications and risk of scleroderma renal crisis
por: Gordon, S. M., et al.
Publicado: (2019)

Scleroderma Renal Crisis With Thrombotic Microangiopathy Treated With Eculizumab
por: Saba, Ludovic, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fdos11qb3kvl1gi04nvuk105u2